|
1) Berger J, Hinglais N. Intracapillary deposits of IgA-IgG. J Urol Nephrol. 1968; 74: 694-5
|
|
|
|
|
2) Hotta O, Miyazaki M, Furuta T, et al. Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy. Am J Kidney Dis. 2001; 38: 736-43
|
|
|
|
|
3) Xie Y, Chen X, Nishi S, et al. Relationship between tonsils and IgA nephropathy as well as indications of tonsillectomy. Kidney Int. 2004; 65: 1135-44
|
|
|
|
|
|
4) Komatsu H, Fujimoto S, Hara S, et al. Effect of tonsillectomy plus steroid pulse therapy on clinical remission of IgA nephropathy: a controlled study. Clin J Am Soc Nephrol. 2008; 3: 1301-7
|
|
|
|
|
|
5) Floege J, Burg M, Kleim V. Recurrent IgA nephropathy after kidney transplantation: not a benign condition. Nephrol Dial Transplant. 1998; 13: 1933-5
|
|
|
|
|
|
6) Cuevas X, Lloveras J, Mir M, et al. Disappearance of mesangial IgA deposits from the kidneys of two donors after transplantation. Transplant Proc. 1987; 19: 2208-9
|
|
|
|
|
|
7) Pierucci A, Fofi C, Bartoli B, et al. Antiendomysial antibodies in Berger's disease. Am J Kidney Dis. 2002; 39: 1176-82
|
|
|
|
|
|
8) Coppo R, Amore A, Gianoglio B, et al. Serum IgA and macromolecular IgA reacting with mesangial matrix components. Contrib Nephrol. 1993; 104: 162-71
|
|
|
|
|
|
9) Suzuki S, Nakatomi Y, Sato H, et al. Haemophilus parainfluenzae antigen and antibody in renal biopsy samples and serum of patients with IgA nephropathy. Lancet. 1994; 343: 12-6
|
|
|
|
|
|
10) Koyama A, Sharmin S, Sakurai H, et al. Staphylococcus aureus cell envelope antigen is a new candidate for the induction of IgA nephropathy. Kidney Int. 2004; 66: 121-32
|
|
|
|
|
|
11) Allen AC, Bailey EM, Brenchley PE, et al. Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: Observations in three patients. Kidney Int. 2001; 60: 969-73
|
|
|
|
|
|
12) Hiki Y, Odani H, Takahashi M, et al. Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy. Kidney Int. 2001; 59: 1077-85
|
|
|
|
|
|
13) Nochi T, Kiyono H. Innate immunity in the mucosal immune system. Curr Pharm Des. 2006; 12: 4203-13
|
|
|
|
|
|
14) Bene MC, Faure G, Hurault de Ligny B, et al. Immunoglobulin A nephropathy. Quantitative immunohistomorphometry of the tonsillar plasma cells evidences an inversion of the immunoglobulin A versus immunoglobulin G secreting cell balance. J Clin Invest. 1983; 71: 1342-7
|
|
|
|
|
|
15) Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol. 2010; 11: 373-84
|
|
|
|
|
|
16) Suzuki H, Suzuki Y, Narita I, et al. Toll-like receptor 9 affects severity of IgA nephropathy. J Am Soc Nephrol. 2008; 19: 2384-95
|
|
|
|
|
|
17) Sato D, Suzuki Y, Kano T, et al. Tonsillar TLR9 expression and efficacy of tonsillectomy with steroid therapy in IgA nephropathy patients. Nephrol Dial Transplant. 2011 (in press)
|
|
|
|
|
|
18) Barratt J, and Feehally J. IgA nephropathy. J Am Soc Nephrol. 2005; 16: 2088-97
|
|
|
|
|
|
19) Conley ME, Cooper MD, Michael AF. Selective deposition of immunoglobulin A1 in immunoglobulin A nephropathy, anaphylactoid purpura nephritis, and systemic lupus erythematosus. J Clin Invest. 1980; 66: 1432-6
|
|
|
|
|
|
20) Tomino Y, Endoh M, Nomoto Y, et al. Immunoglobulin A1 and IgA nephropathy. N Engl J Med. 1981; 305: 1159-60
|
|
|
|
|
|
21) Coppo R, Amore A. Aberrant glycosylation in IgA nephropathy (IgAN). Kidney Int. 2004; 65: 1544-7
|
|
|
|
|
|
22) Moldoveanu Z, Wyatt RJ, Lee JY, et al. Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels. Kidney Int. 2007; 71: 1148-54
|
|
|
|
|
|
23) Suzuki H, Moldoveanu Z, Hall S, et al. IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1. J Clin Invest. 2008; 118: 629
|
|
|
|
|
|
24) Horie A, Hiki Y, Odani H, et al. IgA1 molecules produced by tonsillar lymphocytes are under-O-glycosylated in IgA nephropathy. Am J Kidney Dis. 2003; 42: 486-96
|
|
|
|
|
|
25) Inoue T, Sugiyama H, Hiki Y, et al. Differential expression of glycogenes in tonsillar B lymphocytes in association with proteinuria and renal dysfunction in IgA nephropathy. Clin Immunol. 2010; 136: 447-55
|
|
|
|
|
|
26) Novak J, Moldoveanu Z, Julian BA, et al. Aberrant glycosylation of IgA1 and anti-glycan antibodies in IgA nephropathy: Role of mucosal immune system. In: Harabuchi Y, editors. Adv Otorhinolaryngol: Recent advances in tonsils and mucosal barriers of the upper airways. vol 72, Basel: Karger; 2011; p.60-3
|
|
|
|
|
|
27) Yamada K, Kobayashi N, Ikeda T, et al. Down-regulation of core 1 β1, 3-galactosyltransferase and Cosmc by Th2 cytokine alters O-glycosylation of IgA1. Nephrol Dial Transplant. 2010; 25: 3890-7
|
|
|
|
|
|
28) Tomana M, Novak J, Julian BA, et al. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J Clin Invest. 1999; 104: 73-81
|
|
|
|
|
|
29) Suzuki H, Fan R, Zhang Z, et al. Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. J Clin Invest. 2009; 119: 1668-77
|
|
|
|
|
|
30) Matousovic K, Novak J, Yanagihara T, et al. IgA-containing immune complexes in the urine of IgA nephropathy patients. Nephrol Dial Transplant. 2006; 21: 2478-84
|
|
|
|
|
|
31) 富野康日己, 堀越 哲, 鈴木祐介. 粘膜免疫の破綻による疾病発症 IgA腎症. In: 清野 宏, 編. 臨床粘膜免疫学. 東京: シナジー社; 2011. p.14-21
|
|
|
|
|